Valmet Q3 Orders Jump 30% to EUR 1.41 Billion as Split Review Advances
ESPOO – October 29, 2026 -- Valmet Oyj's third-quarter orders received rose 30 percent to EUR 1,408 million (EUR 1,083 million), or 25 percent organically, while comparable EBITA climbed 6 percent to EUR 169 million (EUR 159 million).
Biomaterial capital orders reach EUR 552 million on China and Asia-Pacific wins
Growth came from strong biomaterial services intake, continued expansion in Process Performance Solutions and a strong quarter in biomaterial capital projects. Biomaterial capital orders totaled EUR 552 million, including major project wins in China and Asia-Pacific. Biomaterial services orders grew 12 percent organically, with growth across regions, service categories and business areas.
Process Performance Solutions posted 3 percent organic order growth in a low-growth market and a comparable EBITA margin of 20.2 percent.